// App-Quantinova.ai

e17050 : Current treatment trajectory for castration-resistant prostate cancer in the community setting.

Researchers

Presenter

  • Kjel Andrew Johnson

Principal Investigators

  • Jeff Scott

  • Jennifer Webster

Medical Centers

  • Integra Connect, West Palm Beach, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Enzalutamide

  • Sipuleucel-T

  • Cabazitaxel

  • CB-7598

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved